secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLENO THERAPEUTICS INC (SLNO)
CIK:        0001484565
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0001193125-24-133322
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Soleno Therapeutics prices $138M public offering of 3M shares at $46/share
--------------------------------------------------------------------------

- Public offering of 3,000,000 shares at $46.00 per share for gross proceeds of ~$138M.
- Net proceeds estimated at ~$129.3M after underwriting discounts and expenses.
- Underwriters granted 30-day option to purchase up to 450,000 additional shares.
- Proceeds to fund R&D for DCCR (Prader-Willi Syndrome) and general corporate purposes.
- Offering expected to close on or about May 7, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484565/000119312524133322/0001193125-24-133322-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484565/000119312524133322/d808535d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-133322

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer